Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ester J. Filinger"'
Autor:
Ester J. Filinger
Publikováno v:
General Pharmacology: The Vascular System. 25:1039-1043
1. The reserpine-like agent, Ro 4-1284 (2-hydroxy-2ethyl-3-isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11b-[H]benzo (a)quinolizine) releases [ 3 H]noradrenaline ([ 3 H]NA) from prelabelled superior cervical ganglion (cell bodies) and nictitating me
Autor:
Ester J. Filinger
Publikováno v:
General pharmacology. 25(5)
1. The release and the metabolism of [ 3 H]noradrenaline ([ 3 H]NA) induced by tyramine was studied in the superior cervical ganglion (cell bodies) and in the nictitating membrane (nerve endings) of the cat. 2. Exposure of the ganglia to 58.0 and 174
Publikováno v:
General Pharmacology: The Vascular System. 12:481-484
1. 1. The two forms of MAO, A and B, are present in the nictitating membrane and superior cervical ganglion of the cat. 2. 2. The K M for the substrate tyramine differed between both tissues, the affinity of the ganglionar enzyme was almost three tim
Autor:
Ester J. Filinger
Publikováno v:
General pharmacology. 17(6)
1. 1. The deaminated glycol, [3H]DOPEG, is the main metabolite in spontaneous outflow from ganglia labelled with [3H]NA. 2. 2. After exposure to pargyline 0.5 mM, [3H]NMN formation may be the first step of the metabolism of [3H]NA in the cat superior
Publikováno v:
General pharmacology. 20(3)
1. Normal, atrophied and denervated submaxillary glands were incubated with [3H]adenine for 1 h. The accumulation of [3H]adenine, expressed as microCi/g tissue, did not differ significantly when the sympathetically denervated glands were compared wit
Publikováno v:
Naunyn-Schmiedeberg's archives of pharmacology. 304(1)
Fifteen days after duct ligation, the wet weight of the rat submaxillary gland was reduced to 40% of the contralateral control. Under these experimental conditions, the noradrenaline (NA) content expressed as μg/g was 1.2±0.1 in the control glands
Autor:
Ester J. Filinger
Publikováno v:
General Pharmacology: The Vascular System. 20:821-822
1. The levels of platelet MAO activity increase and the frequency of affective symptoms diminish in the depressed chronic schizophrenics treated with nomifensine. 2. Nomifensine has no inhibitory effect in vitro on platelet MAO activity in depressed